| Annual Financials | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 6 | 29 | 32 | 43 | 0 |
| Expenses | 6 | 27 | 28 | 33 | 0 |
| EBITDA | 0 | 2 | 4 | 10 | 0 |
| Operating Profit % | 2 % | 6 % | 11 % | 23 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 2 | 3 | 9 | 0 |
| Tax | 0 | 0 | 0 | 2 | 0 |
| Net Profit | 0 | 1 | 3 | 7 | 0 |
| EPS in ₹ | 0.07 | 0.87 | 2.03 | 6.59 | 0.00 |
Earkart
Earkart
194.60
-10.20
(-4.98%)
There are 2 new updates from the company22 hours ago
View
Key Fundamentals
Market Cap
267.67 Cr
EPS
6.59
PE Ratio
-
Dividend Yield
0.00 %
Industry
-52 Week High
265.95
52 Week Low
135.50
PB Ratio
4.36
Debt to Equity
0.27
Sector
-Actual
Company News
View All News
Earkart Limited has been awarded a government supply contract worth ₹6.25 crore by ALIMCO under the Ministry of Social Justice and Empowerment for supplying components for BTE Digital Hearing Aid kits. The one-time domestic contract is expected to contribute positively to the company's revenue during the contract period.
Earkart Limited's board approved ESOP scheme authorization, appointed N Kothari Associates as secretarial auditor for FY2025-26, and released unaudited financial results for the quarter and half-year ended September 30, 2025. The company completed its IPO during the period, issuing 3,315,000 equity shares at Rs 135 per share, increasing paid-up capital from Rs 1,043.89 lakhs to Rs 1,375.39 lakhs with share premium of Rs 4,097.65 lakhs.
Earkart Limited participated in the world's largest otolaryngology conference in Indianapolis, USA from October 11-13, 2025. The company unveiled its next-generation OMNI platform, a remote diagnostic solution for ENT care. The event attracted over 5,000 ENT specialists, audiologists, and healthcare leaders from more than 75 countries. Earkart's booth featured live demonstrations of OMNI's real-time diagnostics and remote consultation capabilities. Multiple leading specialists expressed interest in adopting the platform after witnessing its capabilities. The company saw increased registration forms at their booth, indicating strong interest in the technology. OMNI is positioned for expansion in North America, Europe, the Middle East, and emerging healthcare markets. Earkart operates with 69% government and 29% private revenue, maintains 49 shop-in-shop clinics across 22 cities, and manufactures hearing aids under brands EQFY, Fame, and Radius.
View more
Growth Rate
Revenue Growth
35.00 %
Net Income Growth
122.58 %
Cash Flow Change
171.00 %
ROE
47.27 %
ROCE
72.34 %
EBITDA Margin (Avg.)
93.71 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6 | 15 | 19 | 30 |
| Fixed Assets | 0 | 0 | 1 | 1 |
| Current Assets | 4 | 14 | 17 | 27 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 15 | 18 | 29 |
| Total Liabilities | 6 | 15 | 19 | 30 |
| Current Liabilities | 1 | 8 | 6 | 10 |
| Non Current Liabilities | 0 | 0 | 0 | 0 |
| Total Equity | 5 | 7 | 13 | 20 |
| Reserve & Surplus | 5 | 7 | 13 | 10 |
| Share Capital | 0 | 0 | 0 | 10 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | 1 | -1 |
| Investing Activities | -2 | 0 | -1 | -1 |
| Operating Activities | -3 | -0 | -1 | 1 |
| Financing Activities | 5 | 0 | 3 | -0 |
Share Holding
| % Holding | Jun 2025 | Sept 2025 | Oct 2025 |
| Promoter | 78.75 % | 57.34 % | 57.34 % |
| FIIs | 0.00 % | 5.14 % | 5.14 % |
| DIIs | 0.00 % | 12.61 % | 12.61 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 20.80 % | 20.80 % |
| Others | 21.25 % | 4.10 % | 4.10 % |
| No of Share Holders | 42 | 42 | 530 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Nov 2025 |  Quarterly Result Announcement | NA | 14 Nov 2025 | 236.90 | 210.75 |
Announcements
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order1 day ago
1 day agoAppointment Of N Kothari & Associates As Secretarial Auditor Of The Company For The FY 2025-266 days ago
6 days agoUnaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended 30 September 2025 Along With Limited Review Report Issued By The Peer Reviewed Auditor M/S Gianender & Associates Chartered Accountants.6 days ago
6 days agoBoard Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Earkart Limited Held On Friday 14 November 2025.6 days ago
6 days agoBoard Meeting Intimation for To Approve And Authorise For Having In-Principle Approval For Employee Stock Option Plan (Plan)
To Approve Incorporation Of Wholly-Owned Subsdiary Outside India
To Approve The Issuance Of Ncds.Nov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 29, 2025
Oct 29, 2025Press Release- EarkartS OMNI Shines At WorldS Largest Otolaryngology ConferenceOct 27, 2025
Oct 27, 2025Clarification On Price Movement At Stock Exchange - Earkart Limited (544549)Oct 24, 2025
Oct 24, 2025Clarification sought from Earkart LtdOct 17, 2025
Oct 17, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Oct 03, 2025
Oct 03, 2025Listing of Equity Shares of Earkart LtdOct 03, 2025
Oct 03, 2025Technical Indicators
RSI(14)
Neutral 52.86
ATR(14)
Volatile 13.70
STOCH(9,6)
Oversold 16.94
STOCH RSI(14)
Oversold 3.33
MACD(12,26)
Bearish 0.00
ADX(14)
Strong Trend 36.75
UO(9)
Bearish 56.28
ROC(12)
Downtrend And Accelerating -13.55
WillR(14)
Neutral -70.50
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
